Literature DB >> 12525895

Antimicrobial resistance and DNA-fingerprinting pattern of Burkholderia cepacia blood isolates.

Takeshi Saika1, Intetsu Kobayashi, Miyuki Hasegawa, Minoru Nishida.   

Abstract

The minimum inhibitory concentrations (MICs) of six antibiotics against 33 strains of Burkholderia cepacia isolated from 33 patients suspected of having sepsis or bacteremia were determined. All the B. cepacia isolates were resistant to gentamicin (MIC(90), >128 microg/ml), and 21.2% were resistant to imipenem (MIC(90), 16 microg/ml). They were susceptible to ciprofloxacin, ceftazidime, and minocycline (MIC(90), 2-8 microg/ml). The 33 blood isolates were classified into 12 types (A-L) by the pulsed-field gel electrophoresis pattern. All 11 of A type, 2/4 of B type, 3/4 of C type, 4/5 of E type, and both G type B. cepacia were isolated from different patients in the same hospital. These results suggest that B. cepacia can spread among patients with sepsis or bacteremia.

Entities:  

Mesh:

Year:  2002        PMID: 12525895     DOI: 10.1007/s10156-002-0200-z

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  3 in total

1.  Comparison of antibiotic susceptibility of Burkholderia cepacia complex organisms when grown planktonically or as biofilm in vitro.

Authors:  E Caraher; G Reynolds; P Murphy; S McClean; M Callaghan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-03       Impact factor: 3.267

2.  Substrate spectrum extension of PenA in Burkholderia thailandensis with a single amino acid deletion, Glu168del.

Authors:  Hyojeong Yi; Karan Kim; Kwang-Hwi Cho; Oksung Jung; Heenam Stanley Kim
Journal:  Antimicrob Agents Chemother       Date:  2012-05-07       Impact factor: 5.191

3.  Twelve positions in a β-lactamase that can expand its substrate spectrum with a single amino acid substitution.

Authors:  Hyojeong Yi; Kwang-Hwi Cho; Yun Sung Cho; Karan Kim; William C Nierman; Heenam Stanley Kim
Journal:  PLoS One       Date:  2012-05-22       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.